Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs

J Shelton, X Lu, JA Hollenbaugh, JH Cho… - Chemical …, 2016 - ACS Publications
Nucleoside, nucleotide, and base analogs have been in the clinic for decades to treat both
viral pathogens and neoplasms. More than 20% of patients on anticancer chemotherapy …

Older and new purine nucleoside analogs for patients with acute leukemias

P Robak, T Robak - Cancer treatment reviews, 2013 - Elsevier
Purine nucleoside analogs (PNAs) compose a class of cytotoxic drugs that have played an
important role in the treatment of hematological neoplasms, especially lymphoid and …

[HTML][HTML] Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T-cell progenitor acute lymphoblastic leukemia

AGL Di Rorà, I Iacobucci, E Imbrogno… - Oncotarget, 2016 - ncbi.nlm.nih.gov
During the last few years many Checkpoint kinase 1/2 (Chk1/Chk2) inhibitors have been
developed for the treatment of different type of cancers. In this study we evaluated the …

Novel clofarabine-based combinations with polyphenols epigenetically reactivate retinoic acid receptor beta, inhibit cell growth, and induce apoptosis of breast cancer …

K Lubecka, A Kaufman-Szymczyk… - International journal of …, 2018 - mdpi.com
An epigenetic component, especially aberrant DNA methylation pattern, has been shown to
be frequently involved in sporadic breast cancer development. A growing body of literature …

Inhibition of breast cancer cell growth by the combination of clofarabine and sulforaphane involves epigenetically mediated CDKN2A upregulation

K Lubecka, A Kaufman-Szymczyk… - … and Nucleic Acids, 2018 - Taylor & Francis
Many antineoplastic nucleoside analogue-based combinatorial strategies focused on
remodelling aberrant DNA methylation patterns have been developed. The number of …

Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia

B Büttner, H Knoth, M Kramer, R Oertel… - Leukemia & …, 2017 - Taylor & Francis
Common side effects of clofarabine (CFB) are liver toxicity, particularly a transient elevation
of transaminases and skin toxicity. We studied the correlation of pharmacokinetic (PK) …

Simultaneous determination of clofarabine and cytarabine in human plasma by LC–MS/MS

B Büttner, R Oertel, J Schetelig, JM Middeke… - … of Pharmaceutical and …, 2016 - Elsevier
Combination of cytostatic agents is a basic principle in the treatment of cancer. For the
treatment of acute myeloid leukemia (AML), purine analogs, like clofarabine and cytarabine …

[PDF][PDF] Syntheses of Clofarabine and Related C2′-β-fluorinated Nucleoside Analogues

G Sivets, A Sivets - Journal of New Developments in Chemistry, 2022 - oap-journals.net
A multistep synthesis of 2-chloro-9-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl) adenine
(clofarabine) is described from methyl β-D-ribofuranoside. A new improved method for …

[HTML][HTML] Dosing-time contributes to chronotoxicity of clofarabine in mice via means other than pharmacokinetics

JJ Luan, YS Zhang, XY Liu, YQ Wang, J Zuo… - The Kaohsiung Journal …, 2016 - Elsevier
To evaluate the time-and dose-dependent toxicity of clofarabine in mice and to further define
the chronotherapy strategy of it in leukemia, we compared the mortality rates, LD 50 s …

[PDF][PDF] Journal of New Developments in Chemistry

G Sivets, A Sivets - 2022 - researchgate.net
A multistep synthesis of 2-chloro-9-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl) adenine
(clofarabine) is described from methyl β-D-ribofuranoside. A new improved method for …